WASHINGTON (May 14, 2020) - The BioCompute Object Specification Project led by a team at the George Washington University has been officially approved for publication as an internationally recognized ...
WASHINGTON--(BUSINESS WIRE)--BioCompute, a collaboration between The George Washington University and the FDA to improve communication of bioinformatics pipelines, today announced a new guidance for ...
A consortium led by the George Washington University (GW) has been refunded for their BioCompute Object Specification Project, thanks to a $2.2 million, five-year grant from the U.S. Food and Drug ...
Researchers from the George Washington University (GW), the U.S. Food and Drug Administration (FDA), and industry leaders published in PLOS Biology, describing a standardized communication method for ...
The U.S. Food and Drug Administration and Washington, D.C.-based George Washington University published a framework to promote standards for bioinformatics research. The framework, called the ...
The George Washington University (GW) and the U.S. Food and Drug Administration (FDA) have published a BioCompute Object Specification Document for research and clinical trial use, which details a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results